Democrats Didn’t Achieve All Their Goals, but Inflation Reduction Act Makes Historic Medicare Changes
Kaiser Health News
AUGUST 12, 2022
First, it would give the federal government the ability to negotiate prices of some drugs purchased by Medicare beneficiaries, a tool that has long been opposed by the drug industry. Department of Health and Human Services to identify Medicare’s 100 most expensive drugs and then pick 10 for price negotiations starting in 2023.
Let's personalize your content